Managing Director
Current• Strategy advisor to biomedical executives, project teams, and investors.• Author of "The Pharmagellan Guide to Biotech Forecasting and Valuation" & “The Pharmagellan Guide to Analyzing Biotech Clinical Trials”• Academic researcher on biopharma strategy and policy (Nat Rev Drug Disc, Surgery, BMJ Open, etc.)